• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Asia Pacific Lancet Pen Needels Market Share

    ID: MRFR/MED/0187-HCR
    90 Pages
    Kinjoll Dey
    October 2025

    Lancet and Pen Needles Market Research Report, By Therapy (Insulin, (GLP-1), Growth Hormones), Gauge (17/18G, 21G, 23G), Needle Length (4mm, 8mm, 12mm), And End Users (Medical Institutions & Research Organizations) – The Asia Pacific Forecast till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Asia Pacific Lancet Pen Needels Market Infographic
    Purchase Options

    Market Share

    Asia Pacific Lancet Pen Needels Market Share Analysis

    The Asia Pacific Lancet and Pen Needles market is a rapidly growing segment within the healthcare industry, demanding strategic market share positioning strategies. Companies operating in this region employ various approaches to secure a significant market share and address the diverse needs of diabetic patients who rely on lancets and pen needles for blood glucose monitoring and insulin administration. The cultural and demographic variations in the Asia-Pacific region lead companies to commercialize lancets and pen needles which have been taking into consideration different sections of the people. The due part of the process implies approaches to the variety of ethnicity, life styles, and planned preferences ensuring more reaching market coverage and satisfying peculiar needs of various types of consumers. Companies work on estimating local economic factors, level of income and come up with pricing structure which is affordable and maintain quality. Strategic pricing increases accessibility, rendering it more accommodating besides alluring a broader spectrum of customers and having a favorable impact on market share. Compliance to the regional standards is decisive. At Asia-Pacific countries, companies meet the regulatory requirement on safety and quality endpoints by ensuring that their lancets and pen needles conform. Regulatory compliance promotes credibility of the product, helps develop trust between health care professionals and patients and affects market position positively. The market share position is offered as one of the main approaches for investing into educational campaigns. There are awareness campaigns by companies with regard to diabetes management, advising on blood glucose testing and proper insulin use. The brought indirect benefit of education is positive influence over market shares as healthcare providers and patients tend to trust and prefer preferred brands which follows them. Many companies find that tweaking their marketing to suit local tastes and cultural differences is quite important. It varies the promotional materials, campaigns, and informative resources in line with the different cultures in the Asia- Pacific. The heterogeneous nature of the market and localization are aiding in increased brand recognition and acceptance which positively affect the market share. Market share positioning rests on relationship building between marketers and relevant healthcare professionals. Or, regional marketing practices are informed by the companies’ collaborations with physicians, diabetes educators, and health care facilities to discern healthcare protocols in the regions and gain endorsements. Motivated collaborations bring added value and strengthen the dominance of the market by healthcare professionals who recommend certain brands of lancets and pen needles The automation in the Asia-Pacific region demands that digital engagement and telehealth integration should be embraced. Some of the companies pay special attention to the pediatric market; they realized that many children suffer from diabetes. Personalized lancets, pen needles for pediatric application and awareness programs for parents increase the market stake. According to the foregoing, focusing on the management of pediatric diabetes guarantees that the companies target an emerging, specialized niche in the Asia Pacific market. The trends in regional areas knowledge of consumer preference. Companies continuously reanalyze the market to better align their strategies to change. A dynamic approach to market drivers allows companies to determine their positioning strategies in time which helps maintain market share growth in the Asia-Pacific Lancet and Pen Needles market been.

    Author
    Kinjoll Dey
    Research Analyst Level I

    He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.

    Leave a Comment

    Market Summary

    The Asia-Pacific Lancet and Pen Needles market is projected to grow significantly from 1.95 USD Billion in 2024 to 4.93 USD Billion by 2035.

    Key Market Trends & Highlights

    Asia Pacific Lancet and Pen Needles Key Trends and Highlights

    • The market is expected to expand at a compound annual growth rate (CAGR) of 8.81% from 2025 to 2035.
    • By 2035, the market value is anticipated to reach 4.93 USD Billion, indicating robust growth potential.
    • In 2024, the market is valued at 1.95 USD Billion, laying a strong foundation for future expansion.
    • Growing adoption of advanced pen needle technology due to increasing prevalence of diabetes is a major market driver.

    Market Size & Forecast

    2024 Market Size 1.95 (USD Billion)
    2035 Market Size 4.93 (USD Billion)
    CAGR (2025-2035) 8.81%
    Largest Regional Market Share in 2024 latin_america)

    Major Players

    BD. (U.S.), Novo Nordisk A/S (Europe), Ypsomed (Europe), B. Braun Melsungen AG (Europe), HTL-STREFA (Europe), Terumo Corporation (Asia Pacific), Artsana S.p.A. (Europe), Owen Mumford Ltd. (Europe)

    Market Trends

    Asia Pacific Lancet Pen Needels Market Market Drivers

    Market Segment Insights

    Regional Insights

    Key Companies in the Asia Pacific Lancet Pen Needels Market market include

    Industry Developments

    February 2024: Eli Lilly hopes to launch its bestselling antidiabetic medication, specified as Mounjaro (tripeptide), which will be around early next year. Indian health regulatory bodies, including Mounjaro, are currently investigating this.

    According to Minister Mykhailo Fedorov for Digital Transformation in Ukraine, contracts will be signed first about the mass production of attack drones similar to Russian Lancet drones in February 2024. Among them is the kamikaze drone Lancet manufactured by ZALA Aero Group, which has a range of forty kilometers and belongs to Kalashnikov Concern’s large enterprise division, Russian Armaments Manufacturer.

    June 2023: Shilpa Biologicals Private Limited (SBPL), a wholly owned subsidiary of Shilpa Medicare Limited (SML), was granted marketing authorization for its Adalimumab injection in prefilled syringe (PFS). It is a biosimilar for high concentration adalimumab formulation for rheumatoid arthritis treatment.

    During CPHI Japan 2023, SHL Medical introduced Molly modular platform autoinjectors with pre-installed Needle Isolation Technology (NIT).

    September 2022: The Microsoft and Novo Nordisk partnership was announced in September 2022, merging computational services, cloud computing AI and knowledge thirst in drug development as well as Novo Nordisk’s data engineering services.

    On September 2022, Novo Nordisk acquired Forma Therapeutics. That company is committed to changing lives of Sickle cell disease (SCD) patients among other rare blood diseases.

    Market Segmentation

    Intended Audience

    • Pharmaceutical companies
    • Biotechnological institutes
    • Government and Private Laboratories
    • Research and Development (R&D) Companies
    • Medical Research Laboratories
    • Market Research and Consulting Service Providers 

    Asia Pacific Lancet and Pen Needles Market Overview

    • Pharmaceutical companies
    • Biotechnological institutes
    • Government and Private Laboratories
    • Research and Development (R&D) Companies
    • Medical Research Laboratories
    • Market Research and Consulting Service Providers 

    Key Players for Asia Pacific Lancet and Pen Needles Market

    • BD. (U.S.)
    • Novo Nordisk A/S (Europe)
    • Ypsomed (Europe)
    • B. Braun Melsungen AG (Europe)
    • HTL-STREFA (Europe)
    • Terumo Corporation (Asia Pacific)
    • Artsana S.p.A. (Europe)
    • Owen Mumford Ltd. (Europe)

    Report Scope

    Attribute/Metric Details
    Market Size 2030  USD 3.45 Billion 2032
    Compound Annual Growth Rate (CAGR) 12.67% 2032
    Base Year 2021
    Market Forecast Period 2024-2032
    Historical Data 2018 - 2021
    Market Forecast Units Value (USD Million)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Segments Covered Product, technology, application, and end-users.
    Geographies Covered Americas, Europe, Asia Pacific and the Middle East and Africa
    Countries Covered China, Japan, India, Australia, South Korea, Australia, Rest of Asia-Pacific
    Key Companies Profiled BD. (U.S.), Novo Nordisk A/S (Europe), Ypsomed (Europe), B. Braun Melsungen AG (Europe), HTL-STREFA (Europe), Terumo Corporation (Asia Pacific), Artsana S.p.A. (Europe), Owen Mumford Ltd. (Europe).
    Key Market Opportunities Key market opportunities in the Asia Pacific lancet and pen needles market include rising diabetes prevalence, increasing healthcare expenditure, and growing awareness about advanced diabetes management technologies.
    Key Market Dynamics The key market dynamics for the Asia Pacific lancet and pen needles market include rising diabetes prevalence, increasing adoption of self-monitoring blood glucose devices, technological advancements in needle design, growing awareness and patient education, and expanding healthcare infrastructure.

    Market Highlights

    Author

    Kinjoll Dey
    Research Analyst Level I

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM

    FAQs

    1. Definition
      1. Scope of the Study
        1. Research
        2. Assumptions
        3. Limitations
      2. Introduction
      3. Primary Research
      4. Secondary
      5. Market Size Estimation
      6. Restrains
      7. Opportunities
      8. Challenges
      9. Technology Trends & Assessment
    2. Market Factor Analysis
      1. Porters Five Forces Analysis
        1. Bargaining
        2. Bargaining Power of Buyers
        3. Threat of New
        4. Threat of Substitutes
        5. Intensity of Rivalry
      2. Power of Suppliers
      3. Entrants
      4. Value Chain Analysis
      5. Investment Feasibility Analysis
      6. Pricing
      7. Analysis
      8. Chapter 6. Asia Pacific Lancet and Pen Needles, by Therapy
      9. 6.1
      10. Introduction
      11. Insulin
      12. Market Estimates & Forecast, 2017 –
      13. Glucagon-Like Peptide-1 (GLP-1)
      14. Market Estimates & Forecast,
      15. Growth Hormones
      16. Market Estimates & Forecast,
      17. Others
      18. Chapter 7. Asia Pacific Lancet and Pen Needles,
      19. by Gauge
      20. Introduction
      21. 17/18G
      22. Market Estimates & Forecast,
      23. 21G
      24. Market Estimates & Forecast, 2017 –
      25. 23G
      26. Market Estimates & Forecast, 2017 – 2023
      27. 7.5
      28. Others
      29. Chapter 8. Asia Pacific Lancet and Pen Needles, by Needle Length
      30. Introduction
      31. 4mm
      32. Market Estimates & Forecast, 2017 –
      33. 8mm
      34. Market Estimates & Forecast, 2017 – 2023
      35. 8.4
      36. 12mm
      37. Market Estimates & Forecast, 2017 – 2023
      38. Others
      39. Chapter 9 Asia Pacific Lancet and Pen Needles, by End User
      40. Introduction
      41. Hospitals & Clinics
      42. Market Estimates & Forecast, 2017 –
      43. Medical Institutions & Research Organizations
        1. Market
      44. Estimates & Forecast, 2017 – 2023
      45. Others
      46. Chapter 10. Asia
      47. Pacific Lancet and Pen Needles, by Region
      48. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia
        5. Republic of Korea
        6. Rest of Asia Pacific
      49. Chapter 11 Company Landscape
      50. Introduction
      51. Market Share Analysis
      52. Key Development & Strategies
        1. Key Developments
      53. Chapter 12 Company Profiles
      54. BD.
        1. Product Overview
        2. Financials
        3. SWOT Analysis
      55. 12.1.1
      56. Company Overview
      57. 12.2.4
      58. Key Developments
      59. Novo Nordisk A/S
        1. Product Overview
        2. Financial Overview
        3. Key Developments
        4. SWOT Analysis
      60. 12.2.1
      61. Company Overview
      62. Ypsomed
        1. Product Overview
        2. Financial Overview
        3. Key Development
        4. SWOT Analysis
      63. 12.3.1
      64. Company Overview
      65. B. Braun Melsungen
        1. Company Overview
        2. Product/Business Segment Overview
        3. Financial Overview
        4. Key Development
        5. SWOT Analysis
      66. AG
      67. HTL-STREFA
        1. Company Overview
        2. Product Overview
        3. Financial overview
        4. Key Developments
        5. SWOT
      68. Analysis
      69. Terumo Corporation
        1. Company Overview
        2. Financial Overview
        3. Key Developments
        4. SWOT Analysis
      70. 12.6.2
      71. Product Overview
      72. Artsana S.p.A.
        1. Overview
        2. Financials
        3. Key Developments
      73. 12.7.2
      74. Product Overview
      75. 12.7.5
      76. SWOT Analysis
      77. Owen Mumford Ltd.
        1. Overview
        2. Product
        3. Financials
        4. Key Developments
        5. SWOT
      78. Overview
      79. Analysis
      80. Others
      81. Chapter 13 MRFR Conclusion
      82. Key Findings
        1. From CEO’s View Point
        2. Unmet Needs of the Market
      83. Key Companies to Watch
      84. Prediction of Lancet and Pen Needles
      85. industry
      86. Chapter 14 Appendix
    3. LIST OF TABLES
    4. Lancet
      1. and Pen Needles Industry Synopsis, 2020-2027
    5. Asia Pacific Lancet and
      1. Pen Needles Market Estimates and Forecast, 2020-2027, (USD Million)
      2. Table 3
      3. Asia Pacific Lancet and Pen Needles Market by Region, 2020-2027, (USD Million)
    6. Asia Pacific Lancet and Pen Needles Market by Therapy, 2020-2027, (USD
      1. Million)
    7. Asia Pacific Lancet and Pen Needles Market by Gauge, 2020-2027,
      1. (USD Million)
    8. Asia Pacific Lancet and Pen Needles Market by Needle
      1. Length, 2020-2027, (USD Million)
    9. Asia Pacific Lancet and Pen Needles
      1. Market by End Users, 2020-2027, (USD Million)
    10. Japan Lancet and Pen
      1. Needles Market by Therapy, 2020-2027, (USD Million)
    11. Japan Lancet and
      1. Pen Needles Market by Gauge, 2020-2027, (USD Million)
    12. Japan Lancet
      1. and Pen Needles Market by Needle Length, 2020-2027, (USD Million)
      2. Table 11
      3. Japan Lancet and Pen Needles Market by End Users, 2020-2027, (USD Million)
      4. Table
    13. China Lancet and Pen Needles Market by Therapy, 2020-2027, (USD Million)
      1. Table
    14. China Lancet and Pen Needles Market by Gauge, 2020-2027, (USD Million)
      1. Table
    15. China Lancet and Pen Needles Market by Needle Length, 2020-2027, (USD Million)
    16. China Lancet and Pen Needles Market by End Users, 2020-2027, (USD Million)
    17. India Lancet and Pen Needles Market by Therapy, 2020-2027, (USD Million)
    18. India Lancet and Pen Needles Market by Gauge, 2020-2027, (USD Million)
    19. India Lancet and Pen Needles Market by Needle Length, 2020-2027, (USD
      1. Million)
    20. India Lancet and Pen Needles Market by End Users, 2020-2027,
      1. (USD Million)
    21. Republic of Korea Lancet and Pen Needles Market by Therapy,
    22. Republic of Korea Lancet and Pen Needles
      1. Market by Gauge, 2020-2027, (USD Million)
    23. Republic of Korea Lancet
      1. and Pen Needles Market by Needle Length, 2020-2027, (USD Million)
      2. Table 23
      3. Republic of Korea Lancet and Pen Needles Market by End Users, 2020-2027, (USD Million)
    24. Rest of Asia Pacific Lancet and Pen Needles Market by Therapy, 2020-2027,
      1. (USD Million)
    25. Rest of Asia Pacific Lancet and Pen Needles Market by
      1. Gauge, 2020-2027, (USD Million)
    26. Rest of Asia Pacific Lancet and Pen
      1. Needles Market by Needle Lenght, 2020-2027, (USD Million)
    27. Rest of
      1. Asia Pacific Lancet and Pen Needles Market by End Users, 2020-2027, (USD Million)
    28. LIST OF FIGURES
    29. Research Process
    30. Segmentation
      1. for Asia Pacific Lancet and Pen Needles Market
    31. Market Dynamics for
      1. Asia Pacific Lancet and Pen Needles Market
    32. Asia Pacific Lancet and
    33. Pen Needles Market Share, by Therapy 2020
    34. Asia Pacific Lancet and
    35. Pen Needles Market Share, by Gauge 2020
    36. Asia Pacific Lancet and Pen
    37. Needles Market Share, by Needle Lenght 2020
    38. Asia Pacific Lancet and
    39. Pen Needles Market Share, by End Users, 2020
    40. Asia Pacific Lancet and
    41. Pen Needles Market Share, by Region, 2020
    42. Asia Pacific Lancet and
    43. Pen Needles Market Share, by Country, 2020
    44. Asia Pacific Lancet and
      1. Pen Needles: Company Share Analysis, 2020 (%)
    45. BD.: Key Financials
    46. BD.: Segmental Revenue
    47. BD.: Geographical Revenue
      1. Figure
    48. Novo Nordisk A/S: Key Financials
    49. Novo Nordisk A/S: Segmental Revenue
    50. Novo Nordisk A/S: Geographical Revenue
    51. Ypsomed: Key
      1. Financials
    52. Ypsomed: Segmental Revenue
    53. Ypsomed: Geographical
      1. Revenue
    54. B. Braun Melsungen AG: Key Financials
    55. B. Braun
      1. Melsungen AG: Segmental Revenue
    56. B. Braun Melsungen AG: Geographical
      1. Revenue
    57. HTL-STREFA: Key Financials
    58. HTL-STREFA: Segmental
      1. Revenue
    59. HTL-STREFA: Geographical Revenue
    60. Terumo Corporation:
      1. Key Financials
    61. Terumo Corporation: Segmental Revenue
      1. Figure
    62. Terumo Corporation: Geographical Revenue
    63. Artsana S.p.A.: Key Financials
    64. Artsana S.p.A.: Segmental Revenue
    65. Artsana S.p.A.: Geographical
      1. Revenue
    66. Owen Mumford Ltd.: Key Financials
    67. Owen Mumford
      1. Ltd.: Segmental Revenue
    68. Owen Mumford Ltd.: Geographical Revenue

    Lancet and Pen Needles Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials

    Compare Licence

    ×
    Features License Type
    Single User Multiuser License Enterprise User
    Price $4,950 $5,950 $7,250
    Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
    Free Customization
    Direct Access to Analyst
    Deliverable Format
    Platform Access
    Discount on Next Purchase 10% 15% 15%
    Printable Versions